The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US

Earnshaw, S., Graham, C., Amonkar, MM., & Barr, CE. (2006). The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US. Value in Health, 9(3), A163-A163.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

What are the labor market returns to MBAs from broad-access institutions?
Article

Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the United States
Article

The daily association between affect and alcohol use: A meta-analysis of individual participant data
Article

The use of patient experience feedback in rehabilitation quality improvement and codesign activities